Genelux Corporation
USD2.95
-0.02 (-0.67%)
CEO
Thomas D. Zindrick
IPO Date
2023-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.97
Prev. Close
$2.97
Day Low
$2.91
Day High
$3.03
52W Low
$2.29
52W High
$8.54
Market Cap
$0.11B
Volume
0.14M
| 605 |
| $2.97 |
| 12 May 2026 | Zindrick Thomas | President and CEO | S-Sale | Disposed | 2,798 | $2.94 |
| 12 May 2026 | Smalling Ralph | Head of Regulatory | S-Sale | Disposed | 270 | $2.98 |
| 26 Mar 2026 | Smalling Ralph | Head of Regulatory | S-Sale | Disposed | 345 | $2.42 |
| 26 Mar 2026 | Smalling Ralph | Head of Regulatory | S-Sale | Disposed | 240 | $2.51 |
| 26 Mar 2026 | Cappello Joseph | Chief Technical Officer | S-Sale | Disposed | 906 | $2.42 |
| 26 Mar 2026 | Yu Yong | SVP, Clinical Development | S-Sale | Disposed | 906 | $2.42 |
| 26 Mar 2026 | Zindrick Thomas | President and CEO | S-Sale | Disposed | 3,582 | $2.42 |
| 3 Mar 2026 | Thomas John | director | S-Sale | Disposed | 10,000 | $2.90 |